Product Information
LITHIUM CARBONATE 300 MG TAB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1934 per EA under NDC 00054852825. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054852825
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
New Drug (NDA)
FDA Application
NDA018558On Market Since
6/14/1982
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE 300 MG TAB has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 19.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1934 per EA |
|---|---|
| All-time high | $0.1934 (Jun 24, 2026) |
| All-time low | $0.1194 (Aug 23, 2023) |
| 52-week high | $0.1934 |
| 52-week low | $0.1877 |
| Median price | $0.1531 |
| Average price | $0.1540 |
| Largest weekly change | -20.2% (Nov 20, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE 300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE 300 MG TAB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1934 per EA (NDC 00054852825), effective Jun 24, 2026.
How has the price of LITHIUM CARBONATE 300 MG TAB changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE 300 MG TAB has risen 19.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE 300 MG TAB?
Since Nov 28, 2013, the NADAC for LITHIUM CARBONATE 300 MG TAB has ranged from a low of $0.1194 (Aug 23, 2023) to a high of $0.1934 (Jun 24, 2026), with a median of $0.1531 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE 300 MG TAB?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LITHIUM CARBONATE 300 MG CAP, is $0.0959 per EA — about 50% below LITHIUM CARBONATE 300 MG TAB.
Who manufactures LITHIUM CARBONATE 300 MG TAB?
LITHIUM CARBONATE 300 MG TAB (NDC 00054852825) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification